Published • loading... • Updated
OncoSil (ASX:OSL) puts a A$98m revenue number on a A$43m market cap
Summary by Stocks Down Under
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
OncoSil (ASX:OSL) puts a A$98m revenue number on a A$43m market cap
A 70% gross margin at scale reframes how the Macquarie Park manufacturing build should be valued OncoSil Medical (ASX:OSL) has dropped its mid-July investor presentation, and for a company that spent years being a regulatory story, this deck reads like a commercial one. The headline number is a A$98 million revenue opportunity from the new Sydney manufacturing facility at roughly 70% gross margin at full capacity. Against a A$43 million market c…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
